-- 根據週一提交給香港交易所的文件，Aceso Life Science（港交所代號：0474）同意認購其主要股東Imagi Fin Group發行的2,102股股份。 這家建築機械銷售商的股價在周二下午的交易中下跌近1%。 該公司將以每股0.12港元的價格向Imagi Fin Group發行超過13.9億股股份，以支付1.673億港元的對價。 截至週二，Imagi Fin Group持有Aceso Life Science 14.8億股股份。 Aceso Life Science目前持有Imagi Fin Group 2,624股股份，認購完成後，其持股將增加至4,726股。 Imagi Fin Group是Imagi International（港交所代號：0585）的子公司。
Related Articles
Insider Trading
Ciena Insider Sold Shares Worth $1,587,415, According to a Recent SEC Filing
Gary B Smith, Director, President and Chief Executive Officer, on May 01, 2026, sold 2,952 shares in Ciena (CIEN) for $1,587,415. Following the Form 4 filing with the SEC, Smith has control over a total of 275,461 common shares of the company, with 275,461 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/936395/000103255326000019/xslF345X05/edgardoc.xml
$CIEN
Insider Trading
Popular Insider Sold Shares Worth $920,787, According to a Recent SEC Filing
Maria Cristina Gonzalez-Noguera, Executive Vice President, on May 01, 2026, sold 6,200 shares in Popular (BPOP) for $920,787. Following the Form 4 filing with the SEC, Gonzalez-Noguera has control over a total of 11,255 common shares of the company, with 11,255 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/763901/000119312526204495/xslF345X05/ownership.xml
$BPOP
Insider Trading
Samsara Insider Sold Shares Worth $586,410, According to a Recent SEC Filing
Dominic Phillips, Executive Vice President and Chief Financial Officer, on May 01, 2026, sold 19,547 shares in Samsara (IOT) for $586,410. Following the Form 4 filing with the SEC, Phillips has control over a total of 1,544,164 Class A common shares of the company, with 462,801 shares held directly and 1,081,363 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1642896/000189514826000006/xslF345X05/form4-05042026_100559.xml
$IOT